The World Health Organization’s European chief said on May 10 that at least 3,000 people had died in Ukraine since Russia’s invasion in February because they had been unable to access treatments for chronic diseases.
World Health Organization states will consider a resolution against Russia next week after its invasion of Ukraine, including the possible closure of a major regional office in Moscow, a document obtained by Reuters showed on May 5.
A World Health Organization spokesperson on May 3 confirmed that its European region would hold a special meeting next week on the impact of Russia’s invasion of Ukraine on health and healthcare.
Roche warned that Russia’s attack on Ukraine is disrupting the development of a new generation of multiple sclerosis (MS) drugs as the industry has come to disproportionately rely on Eastern Europe for clinical trials.
Boehringer Ingelheim announced the company’s intention to pump €25 billion ($27 billion) into its R&D pipeline over the next five years.
GlaxoSmithKline said on April 6 the company’s consumer arm stopped shipments of supplements and vitamins to Russia as a result of Moscow’s invasion of Ukraine and would prioritize the supply of over-the-counter medicines for basic needs.